Aardvark Therapeutics (AARD) Other Working Capital Changes (2024 - 2026)
Aardvark Therapeutics (AARD) reported Other Working Capital Changes of -$105000.0 for Q1 2026, down 98.11% on a YoY basis from -$5.6 million in Q1 2025, and down 0.96% sequentially from -$104000.0 in Q4 2025.
Aardvark Therapeutics (AARD) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Aardvark Therapeutics (AARD) has 3 years of Other Working Capital Changes data on file, last reported at -$105000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 98.11% year-over-year to -$105000.0; the trailing twelve-month figure through Mar 2026 stood at -$390000.0 (down 74.11% YoY), and the FY2025 full-year result was -$338000.0, down 70.71% from the prior year.
- Other Working Capital Changes retreated to -$105000.0 in Q1 2026, from -$104000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $4.4 million in Q1 2025 to a low of -$254000.0 in Q3 2024.
- A 3-year average of $745000.0 and a median of $332000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 16.85% in 2025, while the deepest fall reached 200.0% in 2025.
- Tracing AARD's Other Working Capital Changes over 3 years: stood at -$89000.0 in 2024, then dropped by 16.85% to -$104000.0 in 2025, then slipped by 0.96% to -$105000.0 in 2026.
- Business Quant data shows AARD's Other Working Capital Changes at -$105000.0 in Q1 2026, -$104000.0 in Q4 2025, and -$100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aardvark Therapeutics | 139.40 Mn | 19.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -105,000.00 |
| Mar 31, 2026 | -105,000.00 |
| Mar 31, 2026 | -105,000.00 |
| Dec 31, 2025 | -104,000.00 |
| Dec 31, 2025 | -104,000.00 |
| Dec 31, 2025 | -104,000.00 |
| Sep 30, 2025 | -100,000.00 |
| Sep 30, 2025 | -100,000.00 |
| Sep 30, 2025 | -100,000.00 |
| Jun 30, 2025 | -81,000.00 |
| Jun 30, 2025 | -81,000.00 |
| Jun 30, 2025 | -81,000.00 |
| Mar 31, 2025 | -53,000.00 |
| Mar 31, 2025 | -53,000.00 |
| Mar 31, 2025 | -53,000.00 |
| Dec 31, 2024 | -89,000.00 |
| Dec 31, 2024 | -89,000.00 |
| Dec 31, 2024 | -89,000.00 |
| Sep 30, 2024 | -55,000.00 |
| Sep 30, 2024 | -55,000.00 |